Vibrotactile sense might improve over time in paediatric subjects with type 1 diabetes—A mid‐term follow‐up using multifrequency vibrometry
Aim Impaired vibrotactile sense, mirroring diabetic peripheral neuropathy, is present among children and adolescents with type 1 diabetes. This study aims to re‐examine the vibrotactile sense of paediatric type 1 diabetes subjects in order to evaluate any alterations in the vibrotactile sense over t...
Saved in:
Published in | Acta Paediatrica Vol. 111; no. 2; pp. 411 - 417 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Norway
Wiley Subscription Services, Inc
01.02.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Aim
Impaired vibrotactile sense, mirroring diabetic peripheral neuropathy, is present among children and adolescents with type 1 diabetes. This study aims to re‐examine the vibrotactile sense of paediatric type 1 diabetes subjects in order to evaluate any alterations in the vibrotactile sense over time.
Methods
A VibroSense Meter I device was used to determine the vibrotactile perception thresholds (VPTs) for seven frequencies from the pulp of index and little fingers and for five frequencies from metatarsal heads one and five on the sole of the foot, of 37 children and adolescents with type 1 diabetes, previously examined in a larger cohort. Subjects were followed up after a median time of 30 months. Z‐scores of VPTs were calculated using previously collected normative data.
Results
Vibrotactile perception thresholds improved over time at low frequencies (especially 16 Hz) on the foot, while not being statistically significant different on the rest of the frequencies, either on hand or foot. VPTs were not correlated with HbA1c.
Conclusion
A mid‐term follow‐up of vibrotactile sense in paediatric subjects with type 1 diabetes shows a conceivable normalization of previously impaired vibrotactile sense on some frequencies on the foot, indicating that vibrotactile sense might fluctuate over time. |
---|---|
Bibliography: | Funding information Funding was received from Lund University, Skåne County Council for Research and Development, Vinnova, Sydvästra Skånes Diabetesförening, the Swedish Diabetes Foundation and the Swedish Childhood Diabetes Foundation. The study was financed by governmental funding of clinical research within the Swedish NHS (National Health Services; ALF) Helena Elding Larsson and Lars B. Dahlin share senior authorship. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0803-5253 1651-2227 1651-2227 |
DOI: | 10.1111/apa.16124 |